CJM-112
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


CJM-112
Target :
InterleukinRelated Pathways :
Immunology/InflammationBioactivity :
CJM-112 is a humanized monoclonal antibody inhibitor that targets interleukin-17A (IL-17A) . It holds potential for research in inflammatory diseases, such as hidradenitis suppurativa, which involve abnormalities in the IL-17A-related pathway.Shipping Conditions :
Cool packStorage Temperature :
-20°C

